Device / Technology News

RSS

Human MicroRNA Panel for gene-expression profiling to be launched by WaferGen Biosystems

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that it will be launching the Human MicroRNA Panel for its innovative service for gene-expression profiling using its SmartChip(TM) Real-Time PCR System.

17 Dec 2009

Phase Forward’s InForm Global Trial Management solution standardized to support early-stage clinical trials

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced that Cancer Research UK’s Drug Development Office – the drug development arm of the world’s largest independent organization dedicated to cancer research – is standardizing on Phase Forward’s InForm™ Global Trial Management solution to support its diverse portfolio of early-stage clinical trials.

17 Dec 2009

Mission Health System to implement RIVA

Mission Health System in Asheville, North Carolina has ordered a RIVA System (Robotic Intravenous Automation) - a self-contained unit for filling IV syringes and bags - from Intelligent Hospital Systems (IH Systems). The Mission Health System, which includes the Memorial and St. Joseph's campuses, will be using the RIVA System on their off-site pharmacy for both centers.

16 Dec 2009

Cohera Medical announces treatment of first patient in TissuGlu study

Cohera Medical Inc. today announced the treatment of the first patient in a study of its lead surgical adhesive product, TissuGlu®. Initiation of the study marks a major milestone in the company's progression of the lead product toward clinical practice.

16 Dec 2009

Makefield Therapeutics to patent applications covering its Hybrid Nanoparticle drug delivery platform

Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.

16 Dec 2009

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.

16 Dec 2009

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has signed a three-year single source provider contract with Novation, the industry's leading supply contracting company, for MAQUET's market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems.

16 Dec 2009

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

State government leaders, Medicaid agencies, hospital and physician associations, and other entities are formulating strategies for tapping federal stimulus money to create interoperable health information exchanges (HIEs).

16 Dec 2009

MDPathways and RNPathways launched to tackle healthcare recruitment and staffing issues

Imagine what it would be like if every physician and nurse took today off…virtual chaos. More than any other industry in the world, people are the most vital resource in healthcare. Pathways, LLC. has solved a complex healthcare recruiting and staffing problem by connecting physicians and nurses to authentic career opportunities.

16 Dec 2009

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

TSO3 Inc. and 3M (MMM) today announced that an agreement has been reached for 3M to be the exclusive supplier and distributor of TSO3's STERIZONE(R) 125L+ Sterilizer. The partnership with TSO3, an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, will include new cycles to reach acute care facilities through 3M's global sales channel.

16 Dec 2009

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.

16 Dec 2009

HealthInsight and HealthMedia join to deliver Internet-based Digital Coaching solutions

HealthInsight, provider of the only value-based health care administration platform, today announced a partnership with HealthMedia, Inc., a Johnson & Johnson company, to deliver Internet-based Digital Coaching™ solutions focused on lifestyle and behavioral change.

16 Dec 2009

Deaths from heart disease peak in December and January, US database reveals

'Tis the season… for a heart attack? According to Dr. Keith Churchwell, associate director of the Vanderbilt Heart and Vascular Institute at Vanderbilt University Medical Center, a US database of 53 million deaths occurring between 1973 and 2001 reveals that deaths from heart disease peak in December and January, with spikes on Christmas and New Year's Day.

16 Dec 2009

EU border security market boosted by unauthorised immigration and illegal drug trafficking

European Union (EU) member states are spending more on protecting their borders, which are increasingly subjected to unauthorised immigration and illegal drug trafficking. High investment in advanced technology security and IT-based systems will boost the border security market.

16 Dec 2009

Eppendorf initiates import ban against Nanosphere's Verigene and Verigene SP systems

Eppendorf has initiated an import ban for Nanosphere, Inc.'s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled "Method for the identification and/or the quantification of a target compound". The import ban covers any and all imports of the respective products into any country of the European Union. Customs authorities are required to confiscate any violating products.

16 Dec 2009

Patient who received Total Artificial Heart and dual transplant celebrates Christmas

Last December, there were only two things 46-year-old Chuck Besen wanted for Christmas… a matching donor heart and kidney. This year, thanks to the SynCardia temporary CardioWest™ Total Artificial Heart and the dual transplant he received at University Medical Center (UMC) in March, Besen will celebrate his first Christmas at home with his 2-year-old son Dylan and his fiancée Jennifer Hokanson.

16 Dec 2009

Lab chip capable of growing cardiac tissue produced by biomedical engineers

Johns Hopkins biomedical engineers, working with colleagues in Korea, have produced a laboratory chip with nanoscopic grooves and ridges capable of growing cardiac tissue that more closely resembles natural heart muscle.

16 Dec 2009

Defentect's radiation detection solution to be installed in major medical facility

Defentect (OTC Bulletin Board: SLNH) is pleased to announce an $80,000 contract for its proprietary CBRNE (Chemical, Biological, Radiological, Nuclear, Explosive) management, monitoring and messaging software platform. Defentect's DM3(TM) and Gammatect(TM) radiation detection solution is to be installed in a major medical facility in the Northeastern US.

16 Dec 2009

ProtoKinetix evaluates major European proposals to expand AAGP technology use

ProtoKinetix Inc. (PKTX) has been approached by a European biopharma investment group with a series of proposals to develop commercial partnerships in the pharmaceutical/cosmetic arenas.

16 Dec 2009

Mouse Hematology: A laboratory manual for scientists

A newly released set of compact and easy-to-use laboratory resources from Cold Spring Harbor Laboratory Press fills this gap. Mouse Hematology features step-by-step protocols for the preparation, enumeration, and microscopic examination of peripheral blood, bone marrow, and other hematopoietic tissues in the mouse

16 Dec 2009

Device / Technology News

Human MicroRNA Panel for gene-expression profiling to be launched by WaferGen Biosystems

Phase Forward’s InForm Global Trial Management solution standardized to support early-stage clinical trials

Mission Health System to implement RIVA

Cohera Medical announces treatment of first patient in TissuGlu study

Makefield Therapeutics to patent applications covering its Hybrid Nanoparticle drug delivery platform

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

MDPathways and RNPathways launched to tackle healthcare recruitment and staffing issues

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

HealthInsight and HealthMedia join to deliver Internet-based Digital Coaching solutions

Deaths from heart disease peak in December and January, US database reveals

EU border security market boosted by unauthorised immigration and illegal drug trafficking

Eppendorf initiates import ban against Nanosphere's Verigene and Verigene SP systems

Patient who received Total Artificial Heart and dual transplant celebrates Christmas

Lab chip capable of growing cardiac tissue produced by biomedical engineers

Defentect's radiation detection solution to be installed in major medical facility

ProtoKinetix evaluates major European proposals to expand AAGP technology use

Mouse Hematology: A laboratory manual for scientists

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News